Real-life data in 115 chronic migraine patients treated with Onabotulinumtoxin A during more than one year

被引：0
|
作者：
I. Aicua-Rapun
E. Martínez-Velasco
A. Rojo
A. Hernando
M. Ruiz
A. Carreres
E. Porqueres
S. Herrero
F. Iglesias
A. L. Guerrero
机构：
[1] Hospital Universitario de Burgos,Neurology Department
[2] Hospital Clínico Universitario de Valladolid,Neurology Department
[3] Hospital Clínico Universitario,Neurology Department
来源：
The Journal of Headache and Pain | 2016年 / 17卷
关键词：
Chronic Migraine; Medication overuse; OnabotulinumtoxinA; Preventatives; Real-life data;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 26 条
  • [11] Is There a Gender Difference in the Response to onabotulinumtoxinA in Chronic Migraine? Insights from a Real-Life European Multicenter Study on 2879 Patients
    Raffaele Ornello
    Fayyaz Ahmed
    Andrea Negro
    Anna Maria Miscio
    Antonio Santoro
    Alicia Alpuente
    Antonio Russo
    Marcello Silvestro
    Sabina Cevoli
    Nicoletta Brunelli
    Fabrizio Vernieri
    Licia Grazzi
    Carlo Baraldi
    Simona Guerzoni
    Anna P. Andreou
    Giorgio Lambru
    Katharina Kamm
    Ruth Ruscheweyh
    Marco Russo
    Paola Torelli
    Elena Filatova
    Nina Latysheva
    Anna Gryglas-Dworak
    Marcin Straburzyński
    Calogera Butera
    Bruno Colombo
    Massimo Filippi
    Patricia Pozo-Rosich
    Paolo Martelletti
    Simona Sacco
    Pain and Therapy, 2021, 10 : 1605 - 1618
  • [12] REAL-LIFE USE OF ONABOTULINUMTOXINA FOR SYMPTOM RELIEF IN PATIENTS WITH CHRONIC MIGRAINE: REPOSE STUDY GERMAN POPULATION
    Kollewe, Katja
    Gaul, Charly
    Gendolla, Astrid
    Sommer, Katherine
    TOXICON, 2021, 190 : S41 - S42
  • [13] Sustained Efficacy, Safety and High Adherence Rate of Onabotulinum Toxin Type A in Chronic Migraine Patients: A Multicentric Prospective Real-Life Study
    Corbelli, Ilenia
    Verzina, Angela
    De Magistris, Ilaria Leone
    De Vanna, Gioacchino
    Eusebi, Paolo
    Mataluni, Giorgia
    Pisani, Antonio
    Prudenzano, Addolorata Maria Pia
    Trojano, Maria
    Delussi, Marianna
    De Tommaso, Marina
    Russo, Antonio
    Silvestro, Marcello
    Tedeschi, Gioacchino
    Calabresi, Paolo
    Sarchielli, Paola
    TOXINS, 2023, 15 (01)
  • [14] SYNCHRONIZE: Real-World Retrospective Safety Analysis of Patients Treated with OnabotulinumtoxinA for More than One Therapeutic Indication
    Forde, Grace
    Brucker, Benjamin M.
    Ifantides, Kimberly Becker
    Patel, Atul T.
    Mayadev, Angeli
    Brown, Theodore
    Ayyoub, Ziyad
    Martinez, Kenneth
    Singh, Ritu
    Nelson, Mariana
    Battucci, Simona
    Yushmanova, Irina
    Ukah, Ahunna
    Rhyne, Christopher
    TOXINS, 2024, 16 (10)
  • [15] Quarterly repeat cycles of onabotulinumtoxinA in chronic migraine patients: the benefits of the prolonged treatment on the continuous responders and quality-of-life conversion rate in a real-life setting
    Antonio Santoro
    Andrea Fontana
    Anna M. Miscio
    Michele M. Zarrelli
    Massimiliano Copetti
    Maurizio A. Leone
    Neurological Sciences, 2017, 38 : 1779 - 1789
  • [16] Quarterly repeat cycles of onabotulinumtoxinA in chronic migraine patients: the benefits of the prolonged treatment on the continuous responders and quality-of-life conversion rate in a real-life setting
    Santoro, Antonio
    Fontana, Andrea
    Miscio, Anna M.
    Zarrelli, Michele M.
    Copetti, Massimiliano
    Leone, Maurizio A.
    NEUROLOGICAL SCIENCES, 2017, 38 (10) : 1779 - 1789
  • [17] Direct-acting Antiviral Agents in Patients with Chronic Hepatitis C: Real-life Data
    Balkan, Ayhan
    Balkan, Yasemin
    Yildirim, Abdullah Emre
    Konduk, Bugra Tolga
    Barutcu, Sezgin
    Daldal, Abdulkadir
    Ugurlu, Kenan
    Seyyar, Mustafa
    Namiduru, Mustafa
    Metin, Taylan
    Gulsen, Murat Taner
    VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, 2021, 27 (02): : 42 - 48
  • [18] EHMTI-0102. Prospective analysis of the use of onabotulinumtoxina (botox®) In the treatment of chronic migraine; real-life data in 299 patients from hull, UK
    M Khalil
    H Zafar
    V Quarshie
    F Ahmed
    The Journal of Headache and Pain, 2014, 15
  • [19] Real-life Data of Glecaprevir/Pibrentasvir in Chronic Hepatitis C Patients: A Single-center Study
    Cabalak, Mehmet
    Bal, Tayibe
    Ocak, Sabahattin
    Bal, Isa Ahmet
    Onlen, Yusuf
    HEPATITIS MONTHLY, 2023, 23 (01)
  • [20] Rapid response to galcanezumab and predictive factors in chronic migraine patients: A 3-month observational, longitudinal, cohort, multicenter, Italian real-life study
    Vernieri, Fabrizio
    Altamura, Claudia
    Brunelli, Nicoletta
    Costa, Carmelina Maria
    Aurilia, Cinzia
    Egeo, Gabriella
    Fofi, Luisa
    Favoni, Valentina
    Lovati, Carlo
    Bertuzzo, Davide
    D'Onofrio, Florindo
    Doretti, Alberto
    Di Fiore, Paola
    Finocchi, Cinzia
    Di Cola, Francesca Schiano
    Ranieri, Angelo
    Colombo, Bruno
    Bono, Francesco
    Albanese, Maria
    Cevoli, Sabina
    Barbanti, Piero
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 (04) : 1198 - 1208
123